FTC says it wants more information about $43B Pfizer-Seagen deal
The Federal Trade Commission wants more information on Pfizer’s takeover of Seagen before it will make a ruling on whether it will clear the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
